Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001666746 | SCV001884593 | benign | not provided | 2021-01-13 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001666746 | SCV005215266 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Ambry Genetics | RCV004953001 | SCV005497280 | likely benign | Inborn genetic diseases | 2024-09-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003948663 | SCV004770983 | likely benign | ASXL3-related disorder | 2023-08-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |